Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of May 13, 2024
In this edition, smoking cessation support uptake at lung cancer screenings, glecirasib may deliver ‘efficacy and tolerability advantages’ and more.
Read the full coverage here:
Uptake of smoking cessation support high when offered at lung cancer screening
Glecirasib may deliver ‘efficacy and tolerability advantages’ for KRAS-mutant lung cancer
‘Substantial geographic disparities’ worsening in cancer clinical trial availability
Deployed military personnel have increased silica in lung tissue
FDA approves Alecensa for certain patients with ALK-positive lung cancer
References:
Lowers H, et al. Int J Environ Res Public Health. 2024;doi:10.3390/ijerph21010091.Press Release
Murray RL, et al. Eur Respir J. 2024;doi:10.1183/13993003.01768-2023.
Sekar RR, et al. JAMA Netw Open. 2024;doi:10.1001/jamanetworkopen.2024.10162.
Shi Y, et al. Abstract 468214. Presented at: ASCO Plenary Series; April 30, 2024.
Collapse
